Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zymeworks (ZYME) Revenue (2021 - 2025)

Zymeworks' Revenue history spans 5 years, with the latest figure at $2.5 million for Q4 2025.

  • On a quarterly basis, Revenue fell 91.9% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $79.3 million, a 21.95% increase, with the full-year FY2025 number at $106.0 million, up 38.87% from a year prior.
  • Revenue hit $2.5 million in Q4 2025 for Zymeworks, down from $25.0 million in the prior quarter.
  • Over the last five years, Revenue for ZYME hit a ceiling of $325.0 million in Q4 2022 and a floor of $1.9 million in Q1 2022.
  • Historically, Revenue has averaged $31.5 million across 5 years, with a median of $9.0 million in 2021.
  • Biggest five-year swings in Revenue: skyrocketed 3962.5% in 2022 and later crashed 94.79% in 2023.
  • Tracing ZYME's Revenue over 5 years: stood at $8.0 million in 2021, then skyrocketed by 3962.5% to $325.0 million in 2022, then crashed by 94.79% to $16.9 million in 2023, then skyrocketed by 83.33% to $31.0 million in 2024, then crashed by 91.9% to $2.5 million in 2025.
  • Business Quant data shows Revenue for ZYME at $2.5 million in Q4 2025, $25.0 million in Q3 2025, and $48.7 million in Q2 2025.